FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB3 days ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
FTC sues drug middlemen for allegedly inflating insulin prices
WEB4 days ago · The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
FTC sues pharmacy benefit managers for inflating price of insulin : …
WEB2 days ago · FTC sues insulin middlemen, saying they pocket billions while patients face high costs Updated September 22, 2024 6:23 PM ET Originally published September 21, 2024 4:06 PM ET By
Federal Trade Commission sues largest drug middlemen for
WEB3 days ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB3 days ago · September 20, 2024 / 3:09 PM EDT / CBS News. Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while ...
FTC sues insulin middlemen, saying they pocket billions while
WEB3 days ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
House lawmakers slam pharmacy middlemen over sky-high drug …
WEBJul 23, 2024 · WASHINGTON — Democratic and Republican lawmakers found common ground with one another at an oversight committee hearing Tuesday, blaming executives from three major pharmacy middlemen groups...
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
Health care giant sues to stop antitrust probe of pharmacy drug middlemen
WEB20 hours ago · A pharmacist retrieves a a medication. (Joe Raedle/Getty Images.) The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs. The interim staff report, which is part of an ongoing inquiry launched in 2022 by the FTC, details how ...
Skip to content